JP Morgan analyst Steven Alexopoulos maintains Webster Finl (NYSE:WBS) with a Neutral and lowers the price target from $61 to $51.
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.